Vera Therapeutics (NASDAQ:VERA) Stock Price Expected to Rise, Scotiabank Analyst Says
Vera Therapeutics (NASDAQ:VERA – Free Report) had its price objective increased by Scotiabank from $55.00 to $65.00 in a research report report published on Monday morning,Benzinga reports. The brokerage currently has a sector outperform rating on the stock. Other equities analysts also recently issued reports about the company. Wolfe Research initiated coverage on Vera Therapeutics […]
Vera Therapeutics (NASDAQ:VERA – Free Report) had its price objective increased by Scotiabank from $55.00 to $65.00 in a research report report published on Monday morning,Benzinga reports. The brokerage currently has a sector outperform rating on the stock. Other equities analysts also recently issued reports about the company. Wolfe Research initiated coverage on Vera Therapeutics […]
